First successful case of platinum-based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations.
Minami OmuraTakeo KosakaEriko AimonoKohei NakamuraHiroshi HongoShuji MikamiHiroshi NishiharaMototsugu OyaPublished in: IJU case reports (2021)
Through a review of clinical outcomes and genetic/pathologic profiling, the presented case provides insights into future management strategies based on the tumor genetic status.